Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
Abbott(ABT) stock is priced at $114.05, giving the company a market capitalization of 197.44B. It carries a P/E multiple of 37.54 and pays a dividend yield of 2.14%.
As of 2026-08-26, Abbott(ABT) stock has fluctuated between $114.01 and $116.72. The current price stands at $114.05, placing the stock +0.0% above today's low and -2.3% off the high.
Abbott(ABT) shares are trading with a volume of 6.96M, against a daily average of 7.55M.
In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.
In the last year, Abbott(ABT) shares hit a 52-week high of $137.49 and a 52-week low of $81.97.
ABT News
The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring Syste...
Abbott Laboratories (NYSE:ABT) received FDA authorization for its Libre Duo 10 Day system, described as the world's first dual glucose ketone sensing biowearabl...
Abbott (ABT) announced U.S. Food and Drug Administration authorization of its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensing technology....
Analyst ratings
81%
of 27 ratingsMore ABT News
Key Points His purchases increased his exposure to pharmaceuticals, medical devices, diagnostics, and diabetes care. AbbVie is relying on drugs like Skyrizi a...
Key Points Abbott Laboratories has faced challenges, but it should successfully overcome them. Johnson & Johnson is performing well, and there could be more t...
Analyst Josh Jennings of TD Cowen maintained a Buy rating on Abbott Laboratories, boosting the price target to $135.00. Unlock powerful investing tools with Ti...
In August 2026, Abbott Laboratories reported stronger-than-expected fiscal Q2 results and raised its annual profit forecast, driven largely by robust demand for...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Abbott (ABT) has reached agreements with three law firms to resolve the Gill case and claims involving approximately 2,000 other individuals relating to the com...
Avricore Health is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration agreement with Abbott (ABT) to s...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.